Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies.
about
Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Development of a FACS-based Sm ...... ds patient-tailored therapies.
@en
Development of a FACS-based Sm ...... ds patient-tailored therapies.
@nl
type
label
Development of a FACS-based Sm ...... ds patient-tailored therapies.
@en
Development of a FACS-based Sm ...... ds patient-tailored therapies.
@nl
prefLabel
Development of a FACS-based Sm ...... ds patient-tailored therapies.
@en
Development of a FACS-based Sm ...... ds patient-tailored therapies.
@nl
P1476
Development of a FACS-based Sm ...... rds patient-tailored therapies
@en
P2093
Jigyasa Arora
P2888
P356
10.1186/1476-9255-12-S1-P5
P433
P577
2015-04-16T00:00:00Z
P5875
P6179
1041780720